Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Jansa, M. Jachymova, M. Skvarilova, H. Sladkova, T. Palecek, M. Aschermann (Prague, Czech Republic). Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension. Eur Respir J 2005; 26: Suppl. 49, 4431

Member's Comments

No comment yet.

Related content which might interest you: Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Upregulation of endothelial nitric oxide synthase in pulmonary artery of infants with pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 694s Year: 2004 Analysis of BMPR2 mutations, and endothelin-1 and nitric oxide synthase genes polymorphisms in pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Pathways in pulmonary arterial hypertension: the future is here Source: Eur Respir Rev 2012 21: 321-327 Year: 2012 Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes Source: Eur Respir J 2002; 20: 52-58 Year: 2002 Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003 Role of nitric oxide pathway in pathogenesis of high altitude pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 551s Year: 2007 Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003 The role of nitric oxide in pathogenesis of high altitude pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1386-1395 Year: 2016 Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction Source: Eur Respir J 2003; 21: 19-24 Year: 2003 Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 881-891 Year: 2008 Infused nitric oxide in experimental pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 Reduce expression of endothelial nitric oxide synthase lead to more severe pulmonary complex vascular lesions associated with HIV Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Physical training and metabolics of nitric oxide in individuals with idiopathic pulmonary arterial hypertension. Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies Year: 2019 Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 Polymorphism of prostacyclin synthase gene in pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Gender specific association of the endothelial nitric oxide synthase (NOS3) gene polymorphisms with allergic diseases Source: Eur Respir J 2005; 26: Suppl. 49, 140s Year: 2005 Tolerance of long term nitric oxide treatment in severe arterial pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 370s Year: 2002